Molecular Partners Ag (MOLN) Net Equity Issued and Repurchased (2021 - 2025)
Molecular Partners Ag (MOLN) posted quarterly Net Equity Issued and Repurchased of -$1248.9 for Q3 2025, down 203.5% on a QoQ basis from $1206.7 in Q2 2025.
Molecular Partners Ag (MOLN) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Net Equity Issued and Repurchased for 3 consecutive years, with -$1248.9 the latest figure, recorded in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,248.86 |
| Sep 30, 2025 | -1,248.86 |
| Jun 30, 2025 | 1,206.68 |
| Jun 30, 2025 | 1,206.68 |
| Mar 31, 2025 | 1.11 |
| Mar 31, 2025 | 1.11 |
| Jun 30, 2024 | -1.11 |
| Jun 30, 2024 | -1.11 |
| Mar 31, 2024 | 1.15 |
| Mar 31, 2024 | 1.15 |
| Sep 30, 2021 | -57.09 Mn |
| Sep 30, 2021 | -57.09 Mn |